• LAST PRICE
    49.4000
  • TODAY'S CHANGE (%)
    Trending Up4.1500 (9.1713%)
  • Bid / Lots
    49.0000/ 1
  • Ask / Lots
    49.4000/ 1
  • Open / Previous Close
    44.9000 / 45.2500
  • Day Range
    Low 44.8500
    High 49.9600
  • 52 Week Range
    Low 3.0334
    High 55.4099
  • Volume
    276,480
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 45.25
TimeVolumeCRBP
09:32 ET352144.85
09:34 ET10045.385
09:36 ET73045.385
09:38 ET85045.89
09:41 ET242645.58
09:43 ET30046.28
09:45 ET20045.46
09:48 ET20046.21
09:50 ET50045.875
09:52 ET30045.895
09:56 ET78045.485
09:57 ET20045.3
10:01 ET80045.68
10:03 ET27345.74
10:06 ET60045.64
10:10 ET30045.62
10:12 ET50045.32
10:14 ET80045.18
10:15 ET10045.045
10:17 ET211845.23
10:19 ET16645.57
10:21 ET28045.44
10:24 ET93345.75
10:26 ET36646.2
10:28 ET30046.42
10:30 ET73946.75
10:33 ET38646.65
10:35 ET98547.025
10:37 ET10046.79
10:39 ET411546.93
10:42 ET20047.16
10:44 ET70047.45
10:46 ET99247.185
10:48 ET165547.18
10:50 ET176147.44
10:51 ET125047.0301
10:53 ET143547.1802
10:55 ET10047.75
10:57 ET50047.6375
11:00 ET30047.7803
11:02 ET60947.88
11:04 ET190047.66
11:06 ET35047.9099
11:08 ET130047.61
11:09 ET85047.25
11:11 ET70047.435
11:13 ET10047.7
11:18 ET20047.635
11:20 ET10047.74
11:22 ET20047.72
11:24 ET30047.96
11:29 ET98347.55
11:31 ET178647.46
11:36 ET109747.75
11:38 ET48847.38
11:40 ET25447.63
11:42 ET80047.235
11:44 ET30046.895
11:45 ET10046.89
11:47 ET30046.69
11:49 ET10046.825
11:51 ET80047.17
11:54 ET30047.18
11:56 ET423447.89
11:58 ET52947.76
12:05 ET165047.79
12:09 ET160048.17
12:12 ET140048.3499
12:16 ET192248.32
12:18 ET10048.28
12:20 ET10048.09
12:21 ET20048.25
12:23 ET10048.22
12:25 ET175047.95
12:27 ET10047.83
12:34 ET20847.64
12:38 ET20047.48
12:43 ET10047.505
12:45 ET38147.525
12:48 ET20047.525
12:50 ET10047.525
12:52 ET162947.2825
12:57 ET10047.175
01:01 ET30047.26
01:06 ET10047.13
01:10 ET10047.17
01:14 ET187047.36
01:15 ET28047.35
01:17 ET232647.275
01:19 ET30047.315
01:21 ET10047.23
01:24 ET20047.32
01:26 ET20047.43
01:30 ET10047.32
01:33 ET60047.35
01:35 ET10047.35
01:39 ET40047.21
01:48 ET131047.07
01:50 ET26247.11
01:51 ET20047.22
02:02 ET20047.255
02:04 ET19447.3329
02:06 ET10047.255
02:09 ET19647.2
02:11 ET10047.205
02:13 ET162247.385
02:15 ET40047.39
02:20 ET20047.51
02:22 ET985648.245
02:24 ET10048.38
02:27 ET265448.15
02:29 ET20048.34
02:31 ET302048.55
02:33 ET10448.92
02:36 ET13648.97
02:38 ET74649
02:40 ET85148.81
02:42 ET63648.82
02:44 ET13648.96
02:45 ET108749.1
02:47 ET299048.9
02:51 ET20049.28
02:54 ET110049.39
02:56 ET64149.34
02:58 ET34149.293
03:00 ET116949.6
03:02 ET43449.72
03:03 ET35949.9
03:05 ET219649.65
03:09 ET10049.8
03:12 ET170049.6
03:14 ET190049.69
03:16 ET70049.5
03:18 ET101949.585
03:20 ET521649.49
03:21 ET90049.385
03:23 ET63649.71
03:25 ET133649.94
03:27 ET116349.96
03:30 ET220049.6828
03:32 ET88049.77
03:34 ET20049.69
03:36 ET54149.81
03:38 ET46349.63
03:39 ET161049.32
03:41 ET63949.45
03:43 ET259249.4
03:45 ET126949.1175
03:48 ET10049.18
03:50 ET76749.06
03:52 ET130349.15
03:54 ET60049.06
03:56 ET855249.29
03:57 ET275549.1546
03:59 ET829149.4
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCRBP
Corbus Pharmaceuticals Holdings Inc
483.6M
-7.1x
---
United StatesALLO
Allogene Therapeutics Inc
485.5M
-1.3x
---
United StatesORIC
Oric Pharmaceuticals Inc
476.7M
-4.2x
---
United StatesNGNE
Neurogene Inc
472.4M
-8.9x
---
United StatesKALV
Kalvista Pharmaceuticals Inc
497.0M
-3.8x
---
United StatesALT
Altimmune Inc
471.5M
-4.5x
---
As of 2024-07-01

Company Information

Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.

Contact Information

Headquarters
500 River Ridge DriveNORWOOD, MA, United States 02062
Phone
617-963-0103
Fax
---

Executives

Independent Chairman of the Board
Alan Holmer
Chief Executive Officer, Director
Yuval Cohen
Chief Financial Officer
Sean Moran
Chief Medical Officer
Dominic Smethurst
Independent Director
Anne Altmeyer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$483.6M
Revenue (TTM)
$0.00
Shares Outstanding
10.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.59
EPS
$-6.97
Book Value
$-1.56
P/E Ratio
-7.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.